ENTITY
Jiangsu Hengrui Medicine

Jiangsu Hengrui Medicine (600276 CH)

403
Analysis
Health CareChina
Jiangsu Hengrui Medicine Co., Ltd. develops, manufactures, and markets a variety of medicines and medicine packing materials. The Company's products include anti-tumor medicines, pain-killers, anti-infection medicines, aluminum foil, and other related products.
more
08 Jun 2020 10:50

SH/​SZ Connect Flow Weekly: BOE, Hengrui, Wuliangye, Gree

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to highlight key stocks and sectors which the mainland investors traded via the...

Logo
339 Views
Share
13 May 2020 07:56

China Health Care - Allocation Boom: Wuxi Biologics/Jinyu Bio-Tech/Hangzhou Tigermed Top Picks

With increased focus on the Health Care sector in light of the COVID-19 pandemic, Health Care allocations reached record levels last month. We...

Logo
436 Views
Share
12 May 2020 09:23

EM Strategy and Chartbook: Remain Overweight EM Vs. EAFE

China (MSCI China, Shanghai Comp., Shenzhen A Share) continues to offer many attractive setups and is a major focus in today’s EM Strategy report....

Logo
414 Views
Share
04 May 2020 01:38

Kintor Pharma IPO Initiation: To Screen, or Not to Screen?

Kintor Pharmaceutical (1762178D CH) is a clinical-stage drug developer with a focus on potential first-in-class and best-in-class drugs for cancers...

Logo
357 Views
Share
03 May 2020 17:18

SH/​SZ Connect Flow Weekly: Active Flows for Vaccine Stocks

In our weekly Shanghai/Shenzhen Connect Ideas series, we aim to highlight key stocks and sectors which the mainland investors traded via the...

Logo
325 Views
Share
x